Status:
COMPLETED
Efficacy of Two Onabotulinum Toxin Doses
Lead Sponsor:
Swiss Paraplegic Research, Nottwil
Conditions:
Neurogenic Bladder
Overactive Detrusor
Eligibility:
All Genders
18-99 years
Brief Summary
The changes in bladder function after the injection of Onabotulinum toxin into the detrusor in individuals with neurogenic bladder overactivity will be investigated retrospectively. The records of all...
Eligibility Criteria
Inclusion
- neurogenic detrusor overactivity
- spinal cord injury
- Onabotulinum toxin injections into the detrusor from 2000-2017
Exclusion
- missing urodynamic values before or after Onabotulinum toxin injections
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2019
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03388086
Start Date
February 1 2018
End Date
July 31 2019
Last Update
August 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Swiss Paraplegic Centre
Nottwil, Canton of Lucerne, Switzerland, 6207